Novalar Pharmaceuticals
San Diego · Founded 2000
About Novalar Pharmaceuticals
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
Company Facts
- Founded: 2000
- Legal name: Novalar Pharmaceuticals, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $67.2M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2010)
- Website: novalar.com
Canonical: https://fsome.com/organization/novalar-pharmaceuticals-8294529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.